Skip to main content

Videos

Videos

Predicting Response to Hormone Therapy in Prostate Cancer With a Post-Prostatectomy MMAI Model – UroToday

Zach Klaassen discusses with Todd Morgan about innovative post-prostatectomy biomarkers. Dr. Morgan presents findings on a ne [...]

Watch this video

Videos

NCCN 2024 Guidelines Endorse Novel Prostate Test for Precision Risk Stratification – UroToday

Rashid Sayyid and Zach Klaassen discuss the 2024 updates to the NCCN Prostate Cancer Guidelines, highlighting the emergence o [...]

Watch this video

Videos

Multimodal AI Informing Treatment Decisions in Advanced Prostate Cancer – Gerhardt Attard

Alicia Morgans interviews Gerhardt Attard about groundbreaking research presented at ESMO 2023, utilizing the STAMPEDE data s [...]

Watch this video

Videos

The Artera AI Model: Advancing Personalized Medicine in Prostate Cancer Treatment | Dan Spratt & Alicia Morgans Discuss NEJM Evidence Manuscript

Dan Spratt joins Alicia Morgans in a conversation on the Artera AI multimodal artificial intelligence model manuscript publis [...]

Watch this video

Videos

Personalizing Prostate Cancer Therapy Using AI-based Predictive Biomarkers – Paul Nguyen

In a discussion with Alicia Morgans, Paul Nguyen highlights the advancing role of predictive biomarkers in prostate cancer tr [...]

Watch this video

Videos

Artera Multi-Modal AI Platform – Guiding Treatment Decisions in Men with Prostate Cancer – Andre Esteva & Felix Feng

Andre Esteva and Felix Feng join Alicia Morgans to discuss the Artera MMAI platform in prostate cancer intended to identify p [...]

Watch this video

Videos

Beyond the NCCN Localized Prostate Cancer Risk Category: The MMAI Prognostic Risk Stratification Model – Jonathan Tward

Jonathan Tward joins Alicia Morgans to discuss advancing prognostic capabilities in prostate cancer risk stratification using [...]

Watch this video

Videos

Multi-Modal Artificial Intelligence (MMAI) Prognostic Biomarker in High-Risk Prostate Cancer – Daniel Spratt

Alicia Morgans and Daniel Spratt discuss an AI-derived multi-modal digital pathology-based biomarker test designed towards im [...]

Watch this video

Videos

Dr. Spratt Highlights the Validation of an MMAI Prognostic Biomarker for Prostate Cancer

Urology Times features a video of Daniel Spratt, MD discussing results demonstrating successful validation of ArteraAI’s MMAI [...]

Watch this video

1 2